AI assistant
DEXCOM INC — Director's Dealing 2021
Apr 7, 2021
30198_dirs_2021-04-07_be11f990-e4bf-4283-afd1-3aea2103175c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2021-04-05
Reporting Person: SAYER KEVIN R (Director, Chairman, CEO & President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-05 | Common Stock | S | 1475 | $365.674 | Disposed | 116003 | Direct |
| 2021-04-05 | Common Stock | S | 3567 | $366.8449 | Disposed | 112436 | Direct |
| 2021-04-05 | Common Stock | S | 1179 | $367.4105 | Disposed | 111257 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2020, and amended effective December 16, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer.
F2: This transaction was executed in multiple trades at prices ranging from $365.120 to $366.108. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3: Included in this number are 42,356 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 11,943 of which were granted on March 8, 2019 and shall vest through March 8, 2022.
F4: This transaction was executed in multiple trades at prices ranging from $366.176 to $367.165. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F5: This transaction was executed in multiple trades at prices ranging from $367.17 to $367.50. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.